Inventor · disambiguated record
John M. Lincecum
Also filed as: LINCECUM JOHN · LINCECUM JOHN M · LINCECUM JOHN MONTEITH
10 granted patents·3 pending applications·54 citations·filing 2006–2025
88Inventor score
Files withALS THERAPY DEVELOPMENT INST6ALS THERAPY DEV INST2BURKLY LINDA C2PERRIN STEVEN2BIOGEN MA INC1
Top patents by PatentIndex Score
13 records- 0195US11692040B2Anti-CD40L antibodies and methods for treating CD40L-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2021·Granted Jul 4, 2023·4 cites·8 claims
- 0295US11014990B2Anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2020·Granted May 25, 2021·6 cites·10 claims
- 0393US10683356B2Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2018·Granted Jun 16, 2020·8 cites·4 claims
- 0490US10106618B2Anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2017·Granted Oct 23, 2018·8 cites·9 claims
- 0588US8435514B2Method for the treatment of neurodegenerative diseasesPERRIN STEVEN·Filed 2009·Granted May 7, 2013·17 cites·1 claims
- 0687US9044459B2Method for the treatment of neurodegenerative diseasesALS THERAPY DEV INST·Filed 2013·Granted Jun 2, 2015·8 cites·4 claims
- 0785US12275793B2Anti-CD40L antibodies and methods for treating CD40L-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2023·Granted Apr 15, 2025·0 cites·11 claims
- 0881US9775899B2Treating neurological disordersBIOGEN MA INC·Filed 2012·Granted Oct 3, 2017·3 cites·24 claims
- 0975US2025263493A1Anti-cd40l antibodies and methods for treating cd40l-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2025·Application pending·0 cites
- 1056US2012183542A1Treating neurological disordersBURKLY LINDA C·Filed 2011·Application pending·0 cites
- 1154US8946301B2Targeting of T-lymphocytes to treat amyotrophic lateral sclerosisALS THERAPY DEV INST·Filed 2012·Granted Feb 3, 2015·0 cites·13 claims
- 1250US2009124993A1Treating neurological disordersBURKLY LINDA C·Filed 2006·Application pending·0 cites
- 1346US8673308B2Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseasesPERRIN STEVEN·Filed 2012·Granted Mar 18, 2014·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when John M. Lincecum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →